AU7854291A - Styryl compounds which inhibit egf receptor protein tyrosine kinase - Google Patents

Styryl compounds which inhibit egf receptor protein tyrosine kinase

Info

Publication number
AU7854291A
AU7854291A AU78542/91A AU7854291A AU7854291A AU 7854291 A AU7854291 A AU 7854291A AU 78542/91 A AU78542/91 A AU 78542/91A AU 7854291 A AU7854291 A AU 7854291A AU 7854291 A AU7854291 A AU 7854291A
Authority
AU
Australia
Prior art keywords
tyrosine kinase
receptor protein
protein tyrosine
egf receptor
styryl compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU78542/91A
Inventor
Michael Chorev
Aviv Gazit
Chaim Gilon
Alexander Levitzki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rorer International Holdings Inc
Original Assignee
Rorer International Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rorer International Holdings Inc filed Critical Rorer International Holdings Inc
Publication of AU7854291A publication Critical patent/AU7854291A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
AU78542/91A 1990-04-27 1991-04-29 Styryl compounds which inhibit egf receptor protein tyrosine kinase Abandoned AU7854291A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51560290A 1990-04-27 1990-04-27
US515602 1990-04-27

Publications (1)

Publication Number Publication Date
AU7854291A true AU7854291A (en) 1991-11-27

Family

ID=24052017

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78542/91A Abandoned AU7854291A (en) 1990-04-27 1991-04-29 Styryl compounds which inhibit egf receptor protein tyrosine kinase

Country Status (2)

Country Link
AU (1) AU7854291A (en)
WO (1) WO1991016892A1 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05301838A (en) * 1991-10-15 1993-11-16 Mitsubishi Kasei Corp Styrene derivative
GB9212673D0 (en) * 1992-06-15 1992-07-29 Celltech Ltd Chemical compounds
GB9222253D0 (en) * 1992-10-23 1992-12-09 Celltech Ltd Chemical compounds
GB9226830D0 (en) * 1992-12-23 1993-02-17 Celltech Ltd Chemical compounds
US5622977A (en) * 1992-12-23 1997-04-22 Celltech Therapeutics Limited Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
GB9304920D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
JPH09500125A (en) * 1993-07-15 1997-01-07 キャンサー リサーチ キャンペーン テクノロジー リミテッド Prodrugs of protein tyrosine kinase inhibitors
IL107736A (en) * 1993-11-24 2001-01-11 Yissum Res Dev Co Pharmaceutical composition for the prevention of septic shock and for the treatment of chronic inflammatory diseases
ATE260911T1 (en) * 1993-12-22 2004-03-15 Celltech R&D Ltd TRISUBSUTITUTED PHENYL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS PHOSPHODIESTERASE (TYPE IV) INHIBITORS
GB9326173D0 (en) * 1993-12-22 1994-02-23 Celltech Ltd Chemical compounds and process
US5519042A (en) * 1994-01-13 1996-05-21 Hoechst Aktiengesellschaft Method of treating hyperproliferative vascular disease
WO1995024190A2 (en) * 1994-03-07 1995-09-14 Sugen, Inc. Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
GB9405046D0 (en) * 1994-03-15 1994-04-27 Unilever Plc Skin treatment composition
US5786354A (en) * 1994-06-21 1998-07-28 Celltech Therapeutics, Limited Tri-substituted phenyl derivatives and processes for their preparation
US6245774B1 (en) 1994-06-21 2001-06-12 Celltech Therapeutics Limited Tri-substituted phenyl or pyridine derivatives
GB9412571D0 (en) 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412573D0 (en) 1994-06-22 1994-08-10 Celltech Ltd Chemical compounds
GB9412672D0 (en) * 1994-06-23 1994-08-10 Celltech Ltd Chemical compounds
GB9523675D0 (en) 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
GB9526246D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9526245D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Chemical compounds
GB9608435D0 (en) * 1996-04-24 1996-06-26 Celltech Therapeutics Ltd Chemical compounds
GB9619284D0 (en) * 1996-09-16 1996-10-30 Celltech Therapeutics Ltd Chemical compounds
GB9622363D0 (en) * 1996-10-28 1997-01-08 Celltech Therapeutics Ltd Chemical compounds
GB9625184D0 (en) * 1996-12-04 1997-01-22 Celltech Therapeutics Ltd Chemical compounds
JP2001507349A (en) 1996-12-23 2001-06-05 セルテック セラピューティックス リミテッド Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
GB9705361D0 (en) 1997-03-14 1997-04-30 Celltech Therapeutics Ltd Chemical compounds
US6420338B1 (en) * 1997-06-13 2002-07-16 New York University Medical Center Inhibition of the Src kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
CA2288854C (en) 1998-11-11 2009-09-15 F. Hoffmann-La Roche Ag Novel indanylidene compounds
EP1000950B1 (en) * 1998-11-11 2004-02-25 F. Hoffmann-La Roche Ag Novel indanylidene compounds
GB9914258D0 (en) 1999-06-18 1999-08-18 Celltech Therapeutics Ltd Chemical compounds
GB9924862D0 (en) 1999-10-20 1999-12-22 Celltech Therapeutics Ltd Chemical compounds
MXPA03010810A (en) 2001-05-29 2004-03-22 Schering Ag Cdk inhibiting pyrimidines, production thereof and their use as medicaments.
DE102004039373A1 (en) * 2004-08-12 2006-02-23 Grünenthal GmbH Para-alkyl-substituted N- (4-hydroxy-3-methoxy-benzyl) -cinnamic acid amides and their use for the preparation of medicaments
WO2011080736A1 (en) 2009-12-29 2011-07-07 Mapi Pharma Hk Limited Intermediate compounds and processes for the preparation of tapentadol and related compounds

Also Published As

Publication number Publication date
WO1991016892A1 (en) 1991-11-14

Similar Documents

Publication Publication Date Title
AU7854291A (en) Styryl compounds which inhibit egf receptor protein tyrosine kinase
AU4651893A (en) Novel tyrosine kinase
DE69233676D1 (en) Receptor Protein Tyrosine Kinase (FLK-1)
AU5180493A (en) HER4 human receptor tyrosine kinase
AU2552492A (en) Raf protein kinase therapeutics
AU3482493A (en) Novel protein tyrosine kinases
IL97872A0 (en) Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit egf receptor tyrosine kinase
AU7971691A (en) Diaminopyrimidine compounds
DE69620477D1 (en) SHOE ADJUSTMENT SYSTEM
AU1498492A (en) Benzoheterocyclic compounds
AU8143094A (en) (tie-2), a novel receptor tyrosine kinase
EP0797581A4 (en) Novel protein tyrosine kinase, jak3
DE69014309T2 (en) LEAF ADJUSTMENT SYSTEM.
AU3256193A (en) 5-isoquinolinesulfonamide derivatives as protein kinase inhibiting agents
EP0509088A4 (en) 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c
EP0455460A3 (en) Tyrosine kinase negative trkb
AU624293B1 (en) Thermo-actuator
EP0527181A4 (en) Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase
AU8691591A (en) Thermo-actuator
AU7687998A (en) Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
AU8822991A (en) Novel protein tyrosine kinase
AU2647292A (en) Coldproof shoes
ZA945372B (en) Tyrosine kinase receptor
EP0674658A4 (en) A novel protein tyrosine kinase.
AU1120895A (en) Novel receptor tyrosine kinase